Molecular mechanism of NLRP3 inflammasome activation
NLRP3炎症小体激活的分子机制
基本信息
- 批准号:10390480
- 负责人:
- 金额:$ 38.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-05-04 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:ATP phosphohydrolaseAlzheimer&aposs DiseaseAtherosclerosisBindingCASP1 geneCrohn&aposs diseaseDataDevelopmentDiabetes MellitusDiseaseEventGoalsGoutIn VitroInflammasomeInflammatoryInheritedInnate Immune SystemInterleukin-1 betaInterleukin-18InvestigationLinkMediatingMolecularNatural ImmunityPathogenesisPathway interactionsPeptidesPeriodicityPhosphorylationPhosphotransferasesPotassiumProtein KinaseProteinsRegulationRoleSignal TransductionStimulusSurfaceSyndromeTestingTherapeutic Interventionautoinflammatorybasehuman diseasein vivoinnovationinsightmacrophagemolecular targeted therapiesnovelnovel therapeutic intervention
项目摘要
Project Summary
NACHT, LRR and PYD domains-containing protein 3 (NLRP3) is a critical component of the
innate immune system that forms the NLRP3 inflammasome, an intracellular molecular platform
that drives caspase-1 activation and the secretion of biologically active IL-1β and IL-18. In addition
to its protective role in innate immunity, aberrant activation of the NLRP3 inflammasome
contributes to the pathogenesis of several inherited and acquired inflammatory disorders, such
as Cryopyrin-associated autoinflammatory syndrome, gout, Crohn's disease, Alzheimer's
disease, diabetes and atherosclerosis. Despite extensive investigation, the molecular mechanism
leading to NLRP3 inflammasome activation remains elusive. Recently, the protein kinase Nek7
has been found to mediate NLRP3 inflammasome activation independently of its kinase activity.
However, it is unknown how Nek7 is mechanistically linked to NLRP3 inflammasome activation.
Our recent studies implicate a critical role for Nek7 phosphorylation in NLRP3 inflammasome
activation. In this application we aim to elucidate the molecular mechanism of Nek7-mediated
NLRP3 inflammasome activation and determine the role of a novel regulator in this pathway. Our
results are expected to provide new mechanistic insights into NLRP3 inflammasome activation
and might guide the development of novel therapeutic strategies for treating NLRP3-driven
inflammatory diseases.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yuan He其他文献
Yuan He的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yuan He', 18)}}的其他基金
Structure and Mechanism of Eukaryotic Transcription Regulation
真核生物转录调控的结构和机制
- 批准号:
10445554 - 财政年份:2022
- 资助金额:
$ 38.01万 - 项目类别:
Structure and Mechanism of Eukaryotic Transcription Regulation
真核生物转录调控的结构和机制
- 批准号:
10625407 - 财政年份:2022
- 资助金额:
$ 38.01万 - 项目类别:
Structure and Mechanism of Non-Homologous End Joining
非同源末端连接的结构和机制
- 批准号:
10546447 - 财政年份:2020
- 资助金额:
$ 38.01万 - 项目类别:
Molecular mechanism of NLRP3 inflammasome activation
NLRP3炎症小体激活的分子机制
- 批准号:
10158435 - 财政年份:2020
- 资助金额:
$ 38.01万 - 项目类别:
Molecular mechanism of NLRP3 inflammasome activation
NLRP3炎症小体激活的分子机制
- 批准号:
10612352 - 财政年份:2020
- 资助金额:
$ 38.01万 - 项目类别:
Structure and Mechanism of Non-Homologous End Joining
非同源末端连接的结构和机制
- 批准号:
10331036 - 财政年份:2020
- 资助金额:
$ 38.01万 - 项目类别:
ROLE OF NEK7 PROTEIN IN NLRP3 INFLAMMASOME ACTIVATION AND INFLAMMATION
NEK7 蛋白在 NLRP3 炎症小体激活和炎症中的作用
- 批准号:
9179168 - 财政年份:2017
- 资助金额:
$ 38.01万 - 项目类别:














{{item.name}}会员




